A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets

Clinical trial NCT07124221 · RECRUITING

Trial details

NCT number: NCT07124221
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperprolactinemia

Start date: 2025-09-12
Primary completion: 2026-11-21
Enrollment: 382

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.